Last Updated on January 20, 2024 by The Health Master
PUNE The Maharashtra Food and Drugs Administration (FDA) has cancelled the licenses of two Blood Centres (Blood Banks), suspended 12 firms and issued show-cause notices to 25 firms for violating various laws.
The two blood centres whose licenses were cancelled were located in Pune and Sangli districts.
Also, the Maharashtra FDA has been able to inspect only 35 per cent of the firms that they were aiming to inspect due to the second C-19 wave’s impact in the months of April, May and June this year.
SB Patil, joint commissioner, Pune Maharashtra FDA, said, “The licenses of the two blood centres were cancelled as they failed:
- To meet the mandatory requirements like enough testing staff for blood testing, blood collection at the camps and also the nursing staff.
- They also did not have the staff for proper record keeping.
- While one of the blood centres is from Pune, one is from Sangli.
Apart from this, Maharashtra FDA has also suspended the following licenses:
- 5 allopathic firms,
- 3 blood centres,
- 2 blood storage centres and
- 1 homoeopathic unit and
- 1 cosmetics unit.
“We have also issued show-cause notices to 25 more firms and are awaiting a reply,” he said.
Patil added that action was taken from April to September this year. “However, we could complete the inspection of only 35% of the targeted firms by September because we got to work only in the past three months due to the impact of the serious second C-19 wave,” said Patil.
Out of the 538 firms that are located within the Pune division, 278 were expected to be done by September 2021 but only 96 were done.
Procedure to obtain license for Blood Centre (Blood Bank)
Latest Notifications: Blood Centre / Bank
Blood Centre (Bank) – requirements at a glance
FAQs – on Blood Bank / Centre (Part-1)
FAQs – on Blood Bank / Centre (Part-2)
FAQs – on Blood Bank / Centre (Part-3)
Mandatory requirements for Blood donation camps
FAQs on Legal Metrology & Blood Bags
Duties of Retail Chemists / Medical Store / Pharmacy
Govt to plan to conduct these 8 studies on Pharma & Medical Devices
Pharma Industry urges NPPA to invoke Para 19 of DPCO 2013
Dr Reddy’s Labs launches generic Ephedrine Sulfate injection
Novartis gets USFDA approval for drug to treat Chronic Leukemia
Govt to amend New Drugs & Clinical Trials Rules
Govt takes important decisions on Pharma & Medical Devices Industry
Govt issued notification for Form 29: License to Mfg drugs for…
NFI 2021: Salient features of 6th Edition of National Formulary of India
Govt releases draft policy for R&D, Pharma and Medical Devices
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
